Clinical Trial Update: A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of VX-522 in participants with cystic fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-522

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: RECRUITING